Latest / The BioHub - by Avetix
Episode 86 - David de Vries - Tr1X
On this episode we're joined by the Co-Founder & CEO of Tr1X, David de Vries.
David and the team are building on the Nobel Prize winning research into T-reg cells of Fred Ramsdell, Shimon Sakaguchi, and Mary Brunkow, pushing that science forward by translating a Type-1 regulatory T cell program into the clinic with one goal - lasting immune balance for patients.
Their lead program TRX103 is in ph1/2 trials for GvHD and Refractory Crohn's, whilst they just received another IND clearance for TRX319, an allogeneic CD19 CAR-Tr1 therapy, to tackle Progressive MS. Tr1X pick hard problems on purpose…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.